A review on clinical cases of rare mold infections and their antifungal treatment strategies
Kaile Zhai, Yuhua Chang, Lin Liu, Ximeng Duan, Shuqin Wang, Xiuyun Li · 2026
Read A review on clinical cases of rare mold infections and their antifungal treatment strategies by Kaile Zhai, Yuhua Chang, Lin Liu, Ximeng Duan, Shuqin Wang, Xiuyun Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13614747.txt.
Description
Kaile Zhai and colleagues gather the case reports on infections by rare wild molds, in this review from twenty twenty-six. As more people live with weak immune systems, these little-known fungi invade more often. They are often misread, or treated the wrong way. The review covers cases from twenty twenty to early twenty twenty-six.
Most rare mold infections, the review finds, still yield to standard antifungal drugs. The deaths cluster in three spots. The mold is barely known, no drug is advised for it, or the mold is resistant by nature and no one suspected it. So naming the mold fast, and testing which drugs work on it, matter as much as the drugs. The authors also survey natural products active against these molds. They fold all of it into a plan, from fast naming to targeted treatment, meant to seed standard protocols.
Catalog record
| CREATOR | Kaile Zhai, Yuhua Chang, Lin Liu, Ximeng Duan, Shuqin Wang, Xiuyun Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 96 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |